|
[1]
|
Ampel, N.M. (2010) New perspectives on coccidioidomycosis. Proceedings of the American Thoracic Socirty, 7,181-185. doi:10.1513/pats.200907-080AL
|
|
[2]
|
Ampel, N.M. (2010) Coccidioidomycosis: A review of recent advances. Clinics in Chest Medicine, 30, 241-251.
doi:10.1016/j.ccm.2009.02.004
|
|
[3]
|
Grant, S.M. and Clissold, S.P. (1990) Fluconazole: A re- view of its pharmacodynamic and pharmacokinetic pro- perties,and therapeutic potential in superficial and sys- temic mycoses. Drugs, 39, 877-916.
doi:10.2165/00003495-199039060-00006
|
|
[4]
|
Silling, G. (2002) Fluconazole: Optimized antifungal the- rapy based on pharmacokinetics. Mycoses, 45, 39-41.
doi:10.1111/j.1439-0507.2002.tb04768.x
|
|
[5]
|
Song, J.C. and Deresinski S. (2005) Hepatotoxicity of an- tifungal agents. Current Opinion in Investigational Drugs, 6, 170-177.
|
|
[6]
|
Gearhart, M.O. (1994) Worsening of liver func-tion with fluconazole and review of azole antifungal hepato-toxicity. The Annuals of Pharmacotherapy, 28, 1177-1181.
|
|
[7]
|
Wells, C. and Lever, A.M. (1992) Dose-dependent flu- conazole hepatotoxicity proven on biopsy and rechallenge. Journal of Infection, 24, 111-112.
doi:10.1016/0163-4453(92)91346-D
|
|
[8]
|
Kim, H. and Bindslev-Jensen, C. (2004) Reported case of severe hepatotox-icity likely due to fluconazole and not desloratadine. Acta Haematologica, 112, 177-178.
doi:10.1159/000079733
|
|
[9]
|
Girois, S.B., Chapuis, F., Decul-lier, E. and Revol, B.G. (2005) Adverse effects of antifungal therapies in invasive fungal infections: Review and meta-analysis. European Journal of Clinical Microbiology & Infectious Disease, 24, 119-130. doi:10.1007/s10096-005-1281-2
|
|
[10]
|
Wang, J.L., Chang, C.H., Young-Xu, Y. and Chan, K.A. (2010) Systematic review and meta-analysis of the toler- ability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection. Antim- icrobial Agents and Chemotherapy, 54, 2409-2419.
doi:10.1128/AAC.01657-09
|
|
[11]
|
Rex, J.H., Pappas, P.G. and Karchmer, A.W. (2003) A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus ampho- tericin B as therapy for candidemia and its conse-quences in nonneutropenic subjects. Clinical Infectious Diseases, 36, 1221-1228.
|
|
[12]
|
Joly, V., Bolard, J. and Yeni, P. (1992) In vitro models for studying toxicity of antifungal agents. Antimicrobial Agents and Chemotherapy, 36, 1799-1804.
|
|
[13]
|
Somchit, N., Hassim, S.M. and Samsudin, S.H. (2002) Itra- conazole- and fluconazole-induced toxicity in rat hepato- cytes: A comparative in vitro study. Human & Experi- mental Toxicology, 21, 43-48.
doi:10.1191/0960327102ht208oa
|
|
[14]
|
Rodriguez, R.J. and Acosta Jr., D. (1995) Comparison of ketoconazole- and fluco-nazole-induced hepatotoxicity in a primary culture system of rat hepatocytes. Toxicology, 96, 83-92. doi:10.1016/0300-483X(94)02911-D
|
|
[15]
|
Rodriguez, R.J. and Acosta Jr., D. (1996) Inhibition of mitochondrial function in isolated rate liver mitochondria by azole antifungals. Journal of Biochemical Toxicology, 11, 127-131.
doi:10.1002/(SICI)1522-7146(1996)11:3<127::AID-JBT4>3.0.CO;2-M
|
|
[16]
|
Somchit, N., Ngee, C.S., Yaakob, A., Ahmad, Z. and Za- karia, Z.A. (2009) Effects of cytochrome p450 inhibitors on itraconazole and fluconazole induced cytotoxicity in hepatocytes. Journal of Toxicology, Article ID: 912320.
doi:10.1155/2009/912320
|
|
[17]
|
Somchit, N., Norshahida, A.R., Hasiah, A.H., Zuraini, A., Sulaiman, M.R. and Noordin, M.M. (2004) Hepatotoxicity induced by antifungal drugs itraconazole and fluco- nazole in rats: A comparative in vivo study. Human & Experimental Toxicology, 23, 519-525.
doi:10.1191/0960327104ht479oa
|
|
[18]
|
Sun, G., Thai, S.F. and Lambert, G.R. (2006) Flucona- zole-induced hepatic cytochrome P450 gene expression and enzymatic activities in rats and mice. Toxicology Let- tes, 164, 44-53. doi:10.1016/j.toxlet.2005.11.015
|
|
[19]
|
Guillaume, M.P., De Prez, C. and Cogan, E. (1996) Sub- acute mitochondrial liver disease in a patient with AIDS: Possible relationship to pro-longed fluconazole administration. The American Journal of Gastroenterology, 91, 165-168.
|
|
[20]
|
Labarga, P., Soriano, V. and Vispo, M.E. (2007) Hepato- toxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients. The Journal of Infectious Diseases, 196, 670-676.
doi:10.1086/520092
|
|
[21]
|
Aranzabal, L., Casado, J.L. and Moya, J. (2005) Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection. Clinical Infectious Disesses, 40, 588-593. doi:10.1086/427216
|
|
[22]
|
Uberti-Foppa, C., De Bona, A. and Morsica, G., (2003) Pretreatment of chronic active hepatitis C in patients co- infected with HIV and hepatitis C virus reduces the he- patotoxicity associated with subsequent antiretroviral therapy. Journal of Acquired Immune Deficiency Syn- dromes, 33, 146-152.
doi:10.1097/00126334-200306010-00005
|
|
[23]
|
Sulkowski, M.S. and Benhamou, Y. (2007) Therapeutic issues in HIV/HCV-coinfected patients. Journal of Viral Hepatitis, 14, 371-386.
doi:10.1111/j.1365-2893.2006.00816.x
|
|
[24]
|
Sulkowski, M.S. (2004) Drug-induced liver injury asso- ciated with antiretroviral therapy that includes HIV-1 pro- tease inhibitors. Clinical Infectious Disesses, 38, S90- S97. doi:10.1086/381444
|
|
[25]
|
Flaman, A.S., Gravel, C., Hashem, A.M., Tocchi, M. and Li, X. (2011) The effect of interfe-ron-alpha on the expression of cytochrome P450 3A4 in human hepatoma cells. Toxicology and Applied Pharmacology, 253, 130- 136. doi:10.1016/j.taap.2011.03.019
|
|
[26]
|
Tanner, A.R. and Powell, L.W. (1979) Corticosteroids in liver disease: Poss-ible mechanisms of action, pharmacology, and rational use. Gut, 20, 1109-1124.
doi:10.1136/gut.20.12.1109
|